Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 38 of 102, showing 5 Applications out of 508 total, starting on record 186, ending on 190

# Protocol No Study Title Investigator(s) & Site(s)

186.

ECCT/21/06/03   VAT00008
    A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the   efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein   Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of age   and older   
Principal Investigator(s)
1. PROF.ELIZABETH ANNE BUKUSI
2. MARICIANAH A ONONO
Site(s) in Kenya
1. Kenya Medical Research Institute (KEMRI) Center for Microbiology Research - Research Care and Training Program (KEMRI CMRRCTP) (Kisumu county)
2. KEMRI CCRButere County Hospital Site (Kakamega county)
3. Aga Khan University Hospital (Nairobi City county)
4. Kenya Medical Research Institute CGHR (Kisumu county)
5. Kenya Medical Research Institute (Nairobi City county)
6. KEMRI/CCR Partners in Health R&D (PHRD (Kiambu county)
7. KAVI-Institute of Clinical Research, University of Nairobi (Nairobi City county)
8. Ganjoni Clinic (Mombasa county)
9. KEMRI-UAMRD-A/K, Kombewa Clinical Research Cente (Kisumu county)
10. KEMRI/Walter Reed Project Research Center (Kericho county)
 
View

187.

ECCT/20/08/03   NIH_PREFER
        Prebiotic galacto-oligosaccharides and lactoferrin for beneficial gut microbiota with iron supplements: an intervention trial in infants in Msambweni, Kwale County, southern coastal Kenya       
Principal Investigator(s)
1. Gary Brittenham
Site(s) in Kenya
Msambweni County Referral Hospital
 
View

188.

ECCT/12/12/01  
        A pilot study to optimise controlled human malaria infections in humans with varying degrees of prior exposure to malaria using P. falciparum sporozoites administered by needle and syringe   
Principal Investigator(s)
1. Bernhards Ogutu
2. Kevin Marsh
Site(s) in Kenya
Kenya Medical Research Institute, Centre for Clinical Research, Nairobi
 
View

189.

ECCT/13/01/01  
        An Open Label Randomized Controlled Phase IIb Trial to Determine the Safety of Oral Fluconazole in Combination with Flucytosine as Compared to Fluconazole Alone   
Principal Investigator(s)
1. Ana-Claire Meyer
2. Judith Kwasa
3. Mark Jacobson
Site(s) in Kenya
1. Family AIDS Care and Education Services, Lumumba Health Center (Kisumu county)
2. Family AIDS Care and Education Services, Suba District Hospital (Homa Bay county)
 
View

190.

ECCT/11/08/05   Rifapentine During Intensive Phase TB Treatment
        Evaluation of a rifapentine-containing regimen for intensive phase treatment of pulmonary tuberculosis   
Principal Investigator(s)
1. Lena Matata
2. Kevin Cain
Site(s) in Kenya
KEMRI/CDC-KISUMU
 
View